Quality control

•  Accredited control and analytical laboratory, conducting physical and chemical tests in a general mode for all departments
•  Microbiological laboratory
•  In-process control laboratories in the departments
•  Microbiological quality control of products and raw materials in SDFD No.3, conducted according to the GMP requirements, was outsourced to a microbiological laboratory of the RSE "Scientific and Practical Center for Sanitary and Epidemiological Expertise and Monitoring"
•  Microbiological quality control of products and raw materials SDFD No.4, conducted according to the GMP requirements, was outsourced to the microbiological laboratory "Tekseru" LLP

The year 2011

The Committee of Pharmacy of the Ministry of Health of the Republic of Kazakhstan conducted an audit and issued an Opinion on compliance with the national standard of good manufacturing practice "ST RK 1617-2006" for the Solid Dosage Forms Department.

The year 2014

Based on the audit results of the Pharmacy Committee of the Ministry of Health of the Republic of Kazakhstan, the Opinion was obtained on the conformity of manufacturing conditions in the Liquid and Soft Dosage forms Department and Quality Control Department with the requirements of good manufacturing practices "ST RK 1617-2006". Also, the Solid Dosage Form Department was re-certified for compliance with the national standard.

The year 2014

During the successful audit conducted by the Ministry of Health of the Republic of Belarus for compliance with the requirements of Standard TAP 030-2013 "Good Manufacturing Practice", the drug products of Nobel AFF were registered in the Republic of Belarus.

2014 - 2015

As a result of the audits carried out by global inspectors of Abbott company from Europe (Netherlands, Italy, Germany) during the period from 2014 to 2015 for compliance with GMP EC, the contract manufacturing of Physiotens® 0.2 mg and 0.4 mg, film-coated tablets is carried out.

The year 2016

Inspection of the quality assurance system of the enterprise, the supplier of the bulk products (manufacturing site) and the actual conditions of the existing manufacturing operations for compliance with the requirements of O’DSt ISO 17021:2009/O’zDSt 2766:2013 (GMP) is performed to export the products to the Republic of Uzbekistan.

The year 2016

Have received a permit to conduct an independent assessment of the safety and quality of products based on the results of the NCED audit

The year 2016

Assessment of the general compliance with the manufacturing organization and drugs quality control rules is performed by PQM experts, for manufacturing of the following drugs: Levozin tablets 250, 500, 750 mg, Moksipres tablets 400 mg, Albezol tablets, 400 mg.

The year 2017

Re-certification of the Solid Dosage Forms Department and the Liquid & Soft Dosage Forms Department for compliance with the national standard of good manufacturing practice ST RK 1617-2006, is conducted by the Committee of Pharmacy of the Ministry of Health of the RK with the receipt of the Opinion on the conformity of manufacturing conditions.

The year 2018

The inspectors of the Committee of Pharmacy of the Ministry of Health of the Republic of Kazakhstan have conducted an audit and issued certificates for compliance with the manufacturing conditions of Solid Dosage Forms Deps No.3 and No.4 with the Good Manufacturing Practices.